Global Neuroscience Antibodies & Assays Market Report 2023: Players Include Abcam, BioLegend, Bio-Rad Laboratories, Cell Signaling Technology and F. Hoffmann-La Roche


Dublin, March 31, 2023 (GLOBE NEWSWIRE) -- The "Neuroscience Antibodies & Assays Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.

This report provides strategists, marketers and senior management with the critical information they need to assess the market.

The global neuroscience antibodies & assays market grew from $3.6 billion in 2022 to $4.04 billion in 2023 at a compound annual growth rate (CAGR) of 12.0%. The neuroscience antibodies & assays market is expected to grow to $6.24 billion in 2027 at a CAGR of 11.5%.

Major players in the neuroscience antibodies & assays market are Abcam PLC, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, GenScript Biotech Corporation, Merck KgaA, Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Siemens Healthineers, Tecan Group Ltd., Thermo Fisher Scientific Inc., and Enzo Life Sciences AG.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

The neuroscience antibodies & assays market consists of sales of antibodies and assay kits and reagents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The neuroscience antibodies & assays are used to study the development, systems, structure and function, disorders, and degeneration of the nervous system. Neuroscience is the study of the nervous system, its working, and diseases related to the nervous system. Antibodies and assays is a medical test that is based on principles of interaction between antigenic epitopes and antibodies, and this test is useful in neuroscience and the study of neurological disorders.

North America was the largest region in the neuroscience antibodies & assays market in 2022. The regions covered in neuroscience antibodies & assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of neuroscience antibodies & assays market products are consumables, and instruments. Consumables are used in many neurological studies and research experiments. Consumable includes assay kits, reagents, and antibodies that enable quantitative and real-time live-cell analysis. The technologies used are molecular diagnostics, clinical chemistry, immunoassays or immunochemistry, and other technologies. The various applications are in vitro diagnostics, research, and drug discovery. The various end users are hospitals and diagnostics centers, academic and research institutes, pharmaceutical and biotechnology companies.

The increasing incidents of neurological illnesses across the globe are expected to propel the growth of the neuroscience antibodies & assays market going forward. Neurological illnesses are disorders and affecting the nervous system and examples of neurological disorders include epilepsy, Alzheimer's disease, dementia and so on.

The rise in the number of neurological illnesses requires more research and development activities for the treatment of these diseases. Antibodies and assays are used in research and development activities to study development, systems, structure and function, and disorders and degeneration of the nervous system. Thus, the neuroscience antibodies & assays market grows with the increase in incidents of neurological illnesses.

For instance, According to World Health Organization, a Switzerland-based health promotion agency 55 million people live with dementia globally, and there are nearly 10 million new cases every year as per 2021 data. According to Alzheimer's Association a US based Non-profit association, 6.5 million people in the US have Alzheimer's disease as per 2022 data. As a result, the increased incidence of neurological illnesses across the world is driving the neuroscience antibodies and assays market forward.

Technological advancements are a key trend gaining popularity in the neuroscience antibodies and assays market. Major companies operating in the market are introducing new technologies such as Cisbio HTRF that works on TR-FRET technology to sustain their position in the market.

In June 2022, Fujirebio, a Japanese multinational biotechnology company, acquired ADx NeuroSciences for an undisclosed amount. With this acquisition, Fujirebio will be able to provide neurodegenerative disease diagnostic solutions at the global level. ADx Neurosciences is a Belgium-based developer of neurodegenerative biomarkers and specialized in developing tailor-made antibodies and assays for pharma and in vitro diagnostics companies.

The countries covered in the neuroscience antibodies & assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Key Attributes:

Report AttributeDetails
No. of Pages200
Forecast Period2023 - 2027
Estimated Market Value (USD) in 2023$4.04 billion
Forecasted Market Value (USD) by 2027$6.24 billion
Compound Annual Growth Rate11.5%
Regions CoveredGlobal

Key Topics Covered:

1. Executive Summary

2. Neuroscience Antibodies & Assays Market Characteristics

3. Neuroscience Antibodies & Assays Market Trends And Strategies

4. Neuroscience Antibodies & Assays Market - Macro Economic Scenario
4.1. COVID-19 Impact On Neuroscience Antibodies & Assays Market
4.2. Ukraine-Russia War Impact On Neuroscience Antibodies & Assays Market
4.3. Impact Of High Inflation On Neuroscience Antibodies & Assays Market

5. Neuroscience Antibodies & Assays Market Size And Growth
5.1. Global Neuroscience Antibodies & Assays Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Neuroscience Antibodies & Assays Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Neuroscience Antibodies & Assays Market Segmentation
6.1. Global Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

  • Consumables
  • Instruments

6.2. Global Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

  • Molecular Diagnostics
  • Clinical Chemistry
  • Immunoassays Or Immunochemistry
  • Others Technologies

6.3. Global Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

  • In Vitro Diagnostics
  • Research
  • Drug Discovery

6.4. Global Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

  • Hospitals And Diagnostics Centers
  • Academic And Research Institutes
  • Pharmaceutical And Technology Companies

7. Neuroscience Antibodies & Assays Market Regional And Country Analysis
7.1. Global Neuroscience Antibodies & Assays Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Neuroscience Antibodies & Assays Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

For more information about this report visit https://www.researchandmarkets.com/r/vglbqb

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

 
Global Neuroscience Antibodies & Assays Market

Contact Data